Company intelligence / Profile preview

Lighthouse Bio

Andorra

Ownership: Private
Development stage: Other

Overview

Lighthouse Biotech provides a platform to individually isolate live, metabolically active circulating tumor cells (CTCs) from patient samples at any disease stage, enabling real-time molecular and metabolic characterization to accelerate precision oncology research and drug development

Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Lighthouse Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lighthouse Bio.

Explore the full profile